Testing the Farapulse and Watchman devices together
Part of Heart & circulation clinical trials.
This trial is for people who need both a special heart treatment called pulsed field ablation (FARAPULSE) and a device to close off a small pouch in the heart (WATCHMAN FLX Pro or WATCHMAN FLX) to prevent strokes. The study will see how well both procedures work when done together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor has decided you need both procedures: the FARAPULSE system to treat an abnormal heart rhythm and the WATCHMAN device to close a part of your heart.
- You are at least 18 years old and can give your own permission to be in the study.
- You can and will come to all the study visits and follow the study rules.
- You have not had any prior treatment for atrial fibrillation using a catheter-based procedure.
- You have not had a stroke or mini-stroke in the last 3 months.
- You are not pregnant and do not plan to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines two procedures at once: a pulsed field ablation to treat atrial fibrillation and a device implant to close the left atrial appendage to reduce stroke risk. It is designed for people in Asia who need both treatments and may benefit from having them together.
This study tracks people with atrial fibrillation (an irregular heartbeat) who get the WATCHMAN FLX Pro device to reduce stroke risk. It collects real-world data on how well the device works and how safe it is.
This trial tests a new type of heart procedure called pulsed field ablation to treat an irregular heartbeat (atrial fibrillation) in people who have already had a device placed to close off a part of the heart (left atrial appendage occlusion). The goal is to see if this safer ablation method can help control your heart rhythm.
This trial tests a new type of ablation called PFA for people with persistent atrial fibrillation. It aims to see if targeting heart tissue changes can improve outcomes.
This trial tests a new device to help doctors safely enter the left side of your heart during a procedure called ablation. If you are already scheduled for an ablation or a combined ablation and left atrial appendage closure, this study may be an option.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
Hear when a new Stroke Prevention in Patients With Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.